Searched for
PFIZER STAKE SALE
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technologyGlaxoSmithKline (GSK) has filed a lawsuit against Pfizer and BioNTech in Delaware federal court, alleging infringement of GSK's patents rel...
Hold Pfizer, target price Rs 4505: ICICI DirectPfizer Ltd., incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 20569.10 Crore) operating in Pharmaceuticals ...
Buy Pfizer, target price Rs 4725: HDFC SecuritiesPfizer Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services and Scrap for the year ending 31-Mar-2022.
Hold Pfizer, target price Rs 4480: ICICI DirectPfizer Ltd., incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 19287.47 Crore) operating in Pharmaceuticals ...
Pfizer to buy 8.1% stake in French vaccines company ValnevaValneva will use the proceeds from Pfizer's equity investment to support its Phase 3 development contribution to the Lyme disease program. ...
Buy Pfizer, target price Rs 4620: Yes SecuritiesPfizer Ltd., incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 20049.17 Crore) operating in Pharmaceuticals ...
Hold Pfizer, target price Rs 5085: ICICI SecuritiesPfizer Ltd., incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 22736.62 Crore) operating in Pharmaceuticals ...
Buy Pfizer, target price Rs 5450: ICICI DirectPfizer Ltd., incorporated in the year 1950, is a Large Cap company (having a market cap of Rs 21946.10 Crore) operating in Pharmaceuticals ...
Accumulate Pfizer, target price Rs 4,640: Anand RathiThe analyst suggested a stoploss at Rs 3800.
Hold Pfizer, target price Rs 4,665: Anand RathiThe pharma major launched its patented product, Zavicefta, in India in H1 FY20. This was the first anti-infective drug launched by Pfizer i...
CCI clears Micromax-Madison India deal, 3 others get go-aheadIn a tweet, the watchdog said it has approved "acquisition of equity stake in Micromax Informatics Limited by Madison India Opportunities T...
Elder Pharma rallies 5% on stake sale reportsAt 09:20 a.m.; Elder Pharma was locked in 5 per cent upper circuit at Rs 357.15. It hit a low of Rs 347.70 in trade today.
- Strides plunges 12.5% as unit sale to Pfizer seen hitting valuation hurdle
Shares of mid-cap pharma company Strides Arcolab plunged as much as 17.5% on Thursday on speculation that a potential sale of its injectabl...
- Pfizer completes sale of animal health biz for Rs 471.60 crore
Pfizer's animal health business has presence primarily in the large animal health and poultry market segments and also includes marketing s...
- Cipla in talks with global cos for research agreement
Mumbai-based drugmaker Cipla is in talks with global pharma majors for a drug research and supply agreement, said a top company executive o...
- Pfizer scans India for shopping options
Pfizer has approached several Indian drugmakers for possible alliances as part of moves to try and bolster revenues threatened by the expir...
- Ranbaxy shares rise on buzz of Pfizer 'counter-offer'
The share price of Ranbaxy Laboratories rose to a 3-year high on Friday based on the rumour that the world’s largest drug maker, Pfizer, ma...